vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($104.1M vs $62.1M, roughly 1.7× Cytek Biosciences, Inc.). GRID DYNAMICS HOLDINGS, INC. runs the higher net margin — -1.4% vs -70.9%, a 69.5% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 3.7%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 12.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
CTKB vs GDYN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $104.1M |
| Net Profit | $-44.1M | $-1.5M |
| Gross Margin | 52.9% | 34.8% |
| Operating Margin | -9.0% | 61.7% |
| Net Margin | -70.9% | -1.4% |
| Revenue YoY | 8.1% | 3.7% |
| Net Profit YoY | -557.1% | -150.6% |
| EPS (diluted) | — | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | $62.1M | $106.2M | ||
| Q3 25 | $52.3M | $104.2M | ||
| Q2 25 | $45.6M | $101.1M | ||
| Q1 25 | $41.5M | $100.4M | ||
| Q4 24 | $57.5M | $100.3M | ||
| Q3 24 | $51.5M | $87.4M | ||
| Q2 24 | $46.6M | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | $-44.1M | $306.0K | ||
| Q3 25 | $-5.5M | $1.2M | ||
| Q2 25 | $-5.6M | $5.3M | ||
| Q1 25 | $-11.4M | $2.9M | ||
| Q4 24 | $9.6M | $4.5M | ||
| Q3 24 | $941.0K | $4.3M | ||
| Q2 24 | $-10.4M | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | 52.9% | 34.0% | ||
| Q3 25 | 52.7% | 33.3% | ||
| Q2 25 | 52.3% | 34.1% | ||
| Q1 25 | 48.6% | 36.8% | ||
| Q4 24 | 58.5% | 36.9% | ||
| Q3 24 | 56.3% | 37.4% | ||
| Q2 24 | 54.6% | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | -9.0% | 0.5% | ||
| Q3 25 | -17.6% | -0.2% | ||
| Q2 25 | -23.3% | -0.1% | ||
| Q1 25 | -36.1% | -2.0% | ||
| Q4 24 | 5.2% | 1.3% | ||
| Q3 24 | -8.2% | 2.4% | ||
| Q2 24 | -18.3% | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | -70.9% | 0.3% | ||
| Q3 25 | -10.5% | 1.1% | ||
| Q2 25 | -12.2% | 5.2% | ||
| Q1 25 | -27.5% | 2.9% | ||
| Q4 24 | 16.8% | 4.5% | ||
| Q3 24 | 1.8% | 4.9% | ||
| Q2 24 | -22.4% | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.05 | ||
| Q2 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $327.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $530.1M |
| Total Assets | $461.5M | $605.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | $90.9M | $342.1M | ||
| Q3 25 | $93.3M | $338.6M | ||
| Q2 25 | $75.5M | $336.8M | ||
| Q1 25 | $95.3M | $325.5M | ||
| Q4 24 | $98.7M | $334.7M | ||
| Q3 24 | $162.3M | $231.3M | ||
| Q2 24 | $177.9M | $256.0M |
| Q1 26 | — | $530.1M | ||
| Q4 25 | $341.7M | $542.1M | ||
| Q3 25 | $378.6M | $537.7M | ||
| Q2 25 | $377.6M | $532.2M | ||
| Q1 25 | $379.6M | $517.4M | ||
| Q4 24 | $395.7M | $517.8M | ||
| Q3 24 | $385.5M | $400.2M | ||
| Q2 24 | $389.1M | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | $461.5M | $612.9M | ||
| Q3 25 | $494.9M | $613.2M | ||
| Q2 25 | $493.3M | $608.9M | ||
| Q1 25 | $482.6M | $590.9M | ||
| Q4 24 | $499.5M | $592.2M | ||
| Q3 24 | $491.2M | $477.3M | ||
| Q2 24 | $483.7M | $443.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $9.9M | ||
| Q3 25 | $-3.9M | $7.0M | ||
| Q2 25 | $108.0K | $14.4M | ||
| Q1 25 | $-125.0K | $9.4M | ||
| Q4 24 | $2.0M | $7.1M | ||
| Q3 24 | $13.2M | $9.2M | ||
| Q2 24 | $6.2M | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $6.1M | ||
| Q3 25 | $-4.6M | $2.9M | ||
| Q2 25 | $-1.5M | $10.2M | ||
| Q1 25 | $-974.0K | $6.0M | ||
| Q4 24 | $1.1M | $4.4M | ||
| Q3 24 | $12.2M | $5.9M | ||
| Q2 24 | $5.2M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 5.7% | ||
| Q3 25 | -8.7% | 2.8% | ||
| Q2 25 | -3.2% | 10.1% | ||
| Q1 25 | -2.3% | 6.0% | ||
| Q4 24 | 1.9% | 4.4% | ||
| Q3 24 | 23.7% | 6.8% | ||
| Q2 24 | 11.0% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 3.6% | ||
| Q3 25 | 1.3% | 3.9% | ||
| Q2 25 | 3.5% | 4.1% | ||
| Q1 25 | 2.0% | 3.3% | ||
| Q4 24 | 1.6% | 2.6% | ||
| Q3 24 | 2.0% | 3.7% | ||
| Q2 24 | 2.3% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.34× | ||
| Q3 25 | — | 5.92× | ||
| Q2 25 | — | 2.73× | ||
| Q1 25 | — | 3.21× | ||
| Q4 24 | 0.21× | 1.56× | ||
| Q3 24 | 14.05× | 2.15× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
GDYN
Segment breakdown not available.
